Literature DB >> 26636561

History of incomplete vaccination may associate with occurrence of hemorrhagic fever with renal syndrome with relieved clinical symptoms.

Yunru Chen1, Xueliang Yang1, Feng Ye1, Tianyan Chen1, Zhengwen Liu1, Yingren Zhao1.   

Abstract

OBJECTIVE: This retrospective study is aimed to investigate the clinical features of the patients with history of incomplete vaccination against hemorrhagic fever with renal syndrome (HFRS).
METHODS: Data of 140 cases of hospitalized patients with HFRS were collected. The patients were divided into incomplete vaccinated group (n = 10) and unvaccinated group (n = 130) according to vaccination status. Demographic, clinical, and laboratory characteristics of the two groups' patients were compared through t test, Pearson χ(2) test, and Mann-Whitney test.
RESULTS: In comparison with the unvaccinated group, the incidence rate of vomiting and hypotensive-shock, the white blood cell (WBC) and platelet count, the level of blood urea nitrogen and albumin, total number of dialysis and hospitalization cost of patients in the incomplete vaccinated group have statistically significant differences.
CONCLUSION: HFRS disease may still occur in individuals with a history of HFRS incomplete vaccination although the symptoms may be mild. Effective vaccination against HFRS needs sufficient doses and booster shot of the vaccine.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Clinical symptoms; hantavirus; vaccine

Mesh:

Substances:

Year:  2015        PMID: 26636561     DOI: 10.1002/jmv.24443

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

1.  Role-playing: an Effective Method for Clinical Novitiate Teaching of Infectious Diseases.

Authors:  Yunru Chen; Xi Zhang; Lei Shi; Xueliang Yang; Xiaojing Liu; Feng Ye; Shumei Lin
Journal:  Med Sci Educ       Date:  2020-10-30

2.  Structure and Function of HLA-A*02-Restricted Hantaan Virus Cytotoxic T-Cell Epitope That Mediates Effective Protective Responses in HLA-A2.1/K(b) Transgenic Mice.

Authors:  Ying Ma; Linfeng Cheng; Bin Yuan; Yusi Zhang; Chunmei Zhang; Yun Zhang; Kang Tang; Ran Zhuang; Lihua Chen; Kun Yang; Fanglin Zhang; Boquan Jin
Journal:  Front Immunol       Date:  2016-08-08       Impact factor: 7.561

3.  Novel Identified HLA-A*0201-Restricted Hantaan Virus Glycoprotein Cytotoxic T-Cell Epitopes Could Effectively Induce Protective Responses in HLA-A2.1/Kb Transgenic Mice May Associate with the Severity of Hemorrhagic Fever with Renal Syndrome.

Authors:  Kang Tang; Linfeng Cheng; Chunmei Zhang; Yusi Zhang; Xuyang Zheng; Yun Zhang; Ran Zhuang; Boquan Jin; Fanglin Zhang; Ying Ma
Journal:  Front Immunol       Date:  2017-12-12       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.